TERAPIA CELULAR Y MEDICINA REGENERATIVA
![Foto de TERAPIA CELULAR Y MEDICINA REGENERATIVA](/img/grupo.png)
![Foto de Johns Hopkins University](/img/noimage_org.png)
Johns Hopkins University
Baltimore, Estados UnidosPublicacións en colaboración con investigadores/as de Johns Hopkins University (1)
2022
-
MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S303-S304